The individual's healthcare in the last 12 months of life costs about 25% of total healthcare costs for that person's life. Should policy makers’ better control end-of-life costs? This is just one of many questions addressed in this segment about weighing the effectiveness of treatment vs. cost. Join us as host Dr. Bill Rutenberg interviews Senior Medical Economist of the Rand Corporation, Geoffrey Joyce PhD.